Passage BIO, Inc. (PASG)

Nasdaq · Biological Products, (No Diagnostic Substances) · Inc. DE

What they're doing

Between 2026-06-21 and 2026-09-19, public records show 3 signals for Passage BIO, Inc.. Most notable: 2026-06-24: Filed 8-K disclosing material agreement, director or officer change; 2026-06-25: Nichols Weston (ten_percent_owner) bought $206k of stock; 2026-09-03: Filed 8-K disclosing material agreement. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.

Generated 2026-09-19 from public records.

Signals, last 12 months

  1. Material 8-K filing
    Filed 8-K disclosing material agreement
  2. Insider purchase
    Nichols Weston (ten_percent_owner) bought $206k of stock
  3. Material 8-K filing
    Filed 8-K disclosing material agreement, director or officer change

Insider transactions

DateInsiderRoleCodeSharesPriceValue
2026-06-25Nichols Westonten percent ownerP50,0554.12$206,227
2026-01-08Chou WilliamdirectorM10,000——
2026-01-08Chou WilliamdirectorS4,07618.44$75,161
2026-01-08Borthwick KathleenofficerM5,000——
2026-01-08Borthwick KathleenofficerS2,06218.44$38,023
2025-09-15Nichols Westonten percent ownerP11,9006.99$83,181
2025-09-12Nichols Westonten percent ownerP19,7836.99$138,283
2025-09-11Nichols Westonten percent ownerP3256.96$2,262
2025-07-24Lynx1 Capital Management LPten percent ownerP66,4235.71$379,275
2025-07-23Lynx1 Capital Management LPten percent ownerP49,3025.74$282,993
2025-07-22Lynx1 Capital Management LPten percent ownerP13,1235.44$71,389
2025-06-26ORBIMED ADVISORS LLCten percent ownerS213,2570.33$70,375
2025-06-25ORBIMED ADVISORS LLCten percent ownerS138,8000.33$45,804
2025-06-24ORBIMED ADVISORS LLCten percent ownerS231,6000.35$81,060
2025-04-24ORBIMED ADVISORS LLCten percent ownerS68,1950.32$21,822
2025-04-23ORBIMED ADVISORS LLCten percent ownerS89,3280.34$30,372
2025-04-22ORBIMED ADVISORS LLCten percent ownerS78,0490.34$26,537
2025-04-17OrbiMed Capital GP VII LLCten percent ownerS77,0900.33$25,440
2025-04-16OrbiMed Capital GP VII LLCten percent ownerS61,6380.33$20,341
2025-04-15OrbiMed Capital GP VII LLCten percent ownerS10,3260.38$3,924
2025-02-11Borthwick KathleenofficerS3,1830.53$1,687
2025-02-10Borthwick KathleenofficerM8,000——
2025-01-14ORBIMED ADVISORS LLCten percent ownerS79,0240.6$47,414
2025-01-13ORBIMED ADVISORS LLCten percent ownerS17,9860.64$11,511
2025-01-10ORBIMED ADVISORS LLCten percent ownerS126,2090.66$83,298
2025-01-08OrbiMed Capital GP VII LLCten percent ownerS75,0070.68$51,005
2025-01-07OrbiMed Capital GP VII LLCten percent ownerS52,5360.71$37,301
2025-01-06OrbiMed Capital GP VII LLCten percent ownerS19,4810.77$15,000
2024-12-27Lynx1 Capital Management LPten percent ownerP373,6450.65$242,869
2024-12-20OrbiMed Capital GP VII LLCten percent ownerS230,3210.6$138,193
2024-12-11ORBIMED ADVISORS LLCten percent ownerS800.8$64
2024-12-10ORBIMED ADVISORS LLCten percent ownerS8,0150.8$6,412
2024-12-09ORBIMED ADVISORS LLCten percent ownerS54,1810.84$45,512
2024-12-06OrbiMed Capital GP VII LLCten percent ownerS20,9030.82$17,140
2024-12-04OrbiMed Capital GP VII LLCten percent ownerS76,2000.79$60,198
2024-11-27Lynx1 Capital Management LPten percent ownerP29,3000.67$19,631
2024-11-26Lynx1 Capital Management LPten percent ownerP167,0550.71$118,609
2024-11-25Lynx1 Capital Management LPten percent ownerP259,9980.56$145,599
2024-09-19ORBIMED ADVISORS LLCten percent ownerS39,3000.71$27,903
2024-09-18OrbiMed Capital GP VII LLCten percent ownerS25,6310.73$18,711
2024-09-17OrbiMed Capital GP VII LLCten percent ownerS111,4000.73$81,322
2024-09-16OrbiMed Capital GP VII LLCten percent ownerS63,1000.74$46,694

Federal contracts

No federal contract actions on record for this recipient mapping.

Lobbying

No federal lobbying filings on record for this client mapping.

Public attention

No Wikipedia pageview data linked to this company.

Recent filings